• AR and ARv7 in TNBC: Prognostic Impact and EPI-001 Mechanism

  2026-06-25

  This study establishes androgen receptor (AR) and its splice variant ARv7 as key prognostic markers in triple-negative breast cancer (TNBC), with elevated expression strongly linked to metastasis and poor survival. The research uniquely demonstrates that targeting AR/ARv7, particularly using the N-terminal domain inhibitor EPI-001, disrupts metastasis and epithelial-mesenchymal transition (EMT) pathways in TNBC models, indicating new directions for therapeutic intervention.

• Kanamycin Sulfate: Water-Soluble Antibiotic for Advanced Res

  2026-06-25

  Kanamycin Sulfate delivers unmatched precision in antibiotic resistance workflows and selective pressure applications, thanks to its high purity and exceptional water solubility. Discover practical protocol upgrades, troubleshooting guidance, and evidence-based workflow innovations to maximize reproducibility in both microbiology and molecular biology labs.

• Prunin Disrupts SVA IRES Translation: Mechanistic Insights

  2026-06-24

  This study demonstrates that prunin, a natural compound, inhibits Senecavirus A (SVA) replication by targeting its internal ribosome entry site (IRES)-mediated translation. The research identifies novel IRES trans-acting factors and provides a mechanistic foundation for antiviral strategy development.

• Nystatin (Fungicidin): Reliable Antifungal Solutions in the

  2026-06-23

  This scenario-driven guide empowers researchers with validated strategies for deploying Nystatin (Fungicidin) (SKU B1993) in cell-based antifungal assays. Drawing on literature and workflow insights, it covers data-backed protocol optimization, product selection, and interpretive best practices for reliable, reproducible results.

• MOG (35-55) Peptide: Benchmark Inducer in Autoimmune Encepha

  2026-06-23

  MOG (35-55), a myelin oligodendrocyte glycoprotein peptide, is the standard reagent for inducing experimental autoimmune encephalomyelitis (EAE) in multiple sclerosis research. Its defined mechanism, robust reproducibility, and precise immunological targets make it indispensable for neuroinflammation assays and autoimmune disease modeling.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Te

  2026-06-22

  DiI (DiIC18(3)) addresses the need for high-contrast, selective plasma membrane labeling in cell biology and neuroscience applications such as neuronal tracing, cell migration assays, and cell fusion analysis. This probe is unsuitable for water-based protocols or intracellular organelle labeling due to its strict lipid bilayer specificity. Researchers should adopt workflow-specific handling and fixation protocols to maximize membrane selectivity and minimize background.

• 25-Hydroxycholesterol Drives AMPK Activation in Tumor Macrop

  2026-06-22

  Xiao et al. reveal a novel mechanism by which 25-hydroxycholesterol (25HC) accumulates in tumor-associated macrophages (TAMs), activating AMPKα through lysosomal signaling and metabolic rewiring. This axis enables immunosuppressive macrophage functions, highlighting new intervention points for modulating antitumor immunity.

• Ridaforolimus Applications: Optimizing mTOR Inhibition in Ca

  2026-06-21

  Ridaforolimus (Deforolimus, MK-8669) stands out as a potent, selective mTOR inhibitor, enabling reproducible control over proliferation and angiogenesis in diverse cancer cell models. This guide provides actionable workflows, troubleshooting insights, and protocol enhancements for maximizing data fidelity in apoptosis and antiproliferative assays with APExBIO’s Ridaforolimus.

• Pifithrin-α (PFTα): Precision p53 Inhibition in Ferroptosis

  2026-06-20

  Discover how Pifithrin-α enables highly selective p53 inhibition, empowering advanced ferroptosis and neurotoxicity research. This article uniquely analyzes the reference study’s mechanistic breakthroughs and offers assay guidance for researchers targeting p53-dependent apoptosis.

• LEE011 Succinate: CDK Inhibitor Protocols in Cancer Research

  2026-06-19

  Ribociclib succinate (LEE011 succinate) stands out as a precision CDK4/6 inhibitor for advanced cancer research, especially HER2-positive metastatic breast cancer models. This article delivers actionable workflows, troubleshooting strategies, and nuanced assay enhancements to help researchers unlock the full antineoplastic potential of LEE011 succinate in cell proliferation and cell cycle studies.

• IgSF6 Deficiency Enhances Macrophage Antibacterial Function

  2026-06-19

  This study reveals that deficiency of the endoplasmic reticulum-localized immunoglobulin IgSF6 strengthens antibacterial responses in intestinal macrophages by promoting ER stress and inflammatory signaling. These findings illuminate a previously uncharacterized regulatory mechanism in gut immunity, with implications for both infection resistance and inflammatory disease susceptibility.

• Technical Guidance for CDK9 Inhibitor (A3294) in Transcripti

  2026-06-18

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor designed for precise inhibition of cyclin dependent kinase 9, supporting studies of transcription elongation and HIV-1 propagation with minimal cytotoxicity. It should not be employed in experiments requiring broad-spectrum CDK inhibition or long-term storage of working solutions.

• Gentamycin Sulfate: Applied Workflows in Resistance Research

  2026-06-18

  Gentamycin Sulfate from APExBIO delivers precision and reliability for dissecting bacterial protein synthesis and resistance mechanisms, especially in Gram-negative models. This guide translates cutting-edge resistance epidemiology into actionable protocols, troubleshooting solutions, and comparative insights that optimize your experimental outcomes.

• CD36-Mediated Lipid Sensing Drives Immune Escape in AML Cell

  2026-06-17

  Guo et al. reveal that CD36 enables acute myeloid leukemia (AML) cells to suppress T cell activity by sensing oxidized lipids and palmitate, activating an immunosuppressive signaling axis. These findings highlight a non-canonical lipid metabolism pathway underlying immune escape and resistance to hypomethylating therapy in AML, offering new angles for therapeutic intervention.

• GSK621 (SKU B6020): Optimizing AMPK Agonist Assays in Metabo

  2026-06-17

  This article provides a scenario-driven, evidence-based guide for biomedical researchers leveraging GSK621 (SKU B6020) as a potent AMPK agonist. It addresses key workflow challenges in acute myeloid leukemia and immunometabolic research, offering practical insights on protocol optimization, data interpretation, and product selection. By integrating recent literature and real-world lab scenarios, the discussion highlights how GSK621 from APExBIO delivers reproducibility and robust assay performance.

15193 records 1/1013 page Next 12345 下5页 Last page